Schäfer C - Search Results

1

Chronic Heavy Alcohol Use is Associated with Upregulated Paneth Cell Antimicrobials in Gastric Mucosa.

Ostaff MJ, Schäfer C, Courth L, Stebe SR, Ott G, Stange EF, Wehkamp J. Ostaff MJ, et al. Among authors: schafer c. Clin Transl Gastroenterol. 2015 Jul 16;6(7):e103. doi: 10.1038/ctg.2015.26. Clin Transl Gastroenterol. 2015. PMID: 26181292 Free PMC article.

2

Antimicrobial host defense in the upper gastrointestinal tract.

Hosaka Y, Koslowski M, Nuding S, Wang G, Schlee M, Schäfer C, Saigenji K, Stange EF, Wehkamp J. Hosaka Y, et al. Among authors: schafer c. Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1151-8. doi: 10.1097/MEG.0b013e3283052ddb. Eur J Gastroenterol Hepatol. 2008. PMID: 18989140

3

Efficacy of double-balloon enteroscopy in the evaluation and treatment of bleeding and non-bleeding small bowel disease.

Schäfer C, Rothfuss K, Kreichgauer HP, Stange EF. Schäfer C, et al. Z Gastroenterol. 2007 Mar;45(3):237-43. doi: 10.1055/s-2007-962823. Z Gastroenterol. 2007. PMID: 17357953

4

Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux.

Igel S, Drescher S, Mürdter T, Hofmann U, Heinkele G, Tegude H, Glaeser H, Brenner SS, Somogyi AA, Omari T, Schäfer C, Eichelbaum M, Fromm MF. Igel S, et al. Among authors: schafer c. Clin Pharmacokinet. 2007;46(9):777-85. doi: 10.2165/00003088-200746090-00005. Clin Pharmacokinet. 2007. PMID: 17713975 Clinical Trial.

5

Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C. Parlesak A, et al. Among authors: schafer c. J Hepatol. 2000 May;32(5):742-7. doi: 10.1016/s0168-8278(00)80242-1. J Hepatol. 2000. PMID: 10845660

6

Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender?

Ammon E, Schäfer C, Hofmann U, Klotz U. Ammon E, et al. Among authors: schafer c. Clin Pharmacol Ther. 1996 May;59(5):503-13. doi: 10.1016/S0009-9236(96)90178-2. Clin Pharmacol Ther. 1996. PMID: 8646821 Clinical Trial.

7

Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.

Schäfer C, Schips I, Landig J, Bode JC, Bode C. Schäfer C, et al. Z Gastroenterol. 1995 Sep;33(9):503-8. Z Gastroenterol. 1995. PMID: 8525652

8

Thrombolytic therapy in patients with portal vein thrombosis: case report and review of the literature.

Schäfer C, Zundler J, Bode JC. Schäfer C, et al. Eur J Gastroenterol Hepatol. 2000 Oct;12(10):1141-5. doi: 10.1097/00042737-200012100-00012. Eur J Gastroenterol Hepatol. 2000. PMID: 11057461 Review.

9

Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease.

Schäfer C, Greiner B, Landig J, Feil E, Schütz ET, Bode JC, Bode C. Schäfer C, et al. J Hepatol. 1997 Mar;26(3):567-73. doi: 10.1016/s0168-8278(97)80422-9. J Hepatol. 1997. PMID: 9075664

10

IgA against gut-derived endotoxins: does it contribute to suppression of hepatic inflammation in alcohol-induced liver disease?

Parlesak A, Schäfer C, Bode C. Parlesak A, et al. Among authors: schafer c. Dig Dis Sci. 2002 Apr;47(4):760-6. doi: 10.1023/a:1014783815433. Dig Dis Sci. 2002. PMID: 11991606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

981 results

Search Page

Filters